Breast Cancer
A PHASE 1B/2, OPEN-LABEL, MULTICOHORT STUDY OF DISITAMAB VEDOTIN IN ADULTS WITH HER2 EXPRESSING ADVANCED BREAST CANCER.(C5731006/SGNDV-006)
- Details
ClinicalTrials.gov ID:
NCT06966453
Diagnosis Type:
NA
USOR Number:
- Address
,
P: